The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs

Marion Wilkens, Michael Bartlett, Frank Willersinn, Karen O'Hara, Jeanette Boyd, Jessica Denning

Source: Breathe, 17 (1) 818; 10.1183/20734735.0340-2020
Journal Issue: March

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marion Wilkens, Michael Bartlett, Frank Willersinn, Karen O'Hara, Jeanette Boyd, Jessica Denning. The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs. Breathe, 17 (1) 818; 10.1183/20734735.0340-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020
Year: 2020

Expanding the awareness of Alpha-1 antitrypsin deficiency (AATD) to provide a multidisciplinary approach to care
Source: Virtual Congress 2020 – Airway diseases
Year: 2020

Research priorities in alpha-1 antitrypsin deficiency (AATD) for healthcare professionals
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020

Alpha-1 antitrypsin deficiency and pulmonary morbidity in patients with primary immunodeficiency disease: A single center experience
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018

Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Alpha-1 antitrypsin deficiency severity and the risk of COVID-19
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021

Alpha-1 antitrypsin deficiency – a potentially fatal disease
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017

Decline in health status in alpha1 antitrypsin deficiency
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019

Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015

Addressing unmet needs in the treatment of COPD
Source: Eur Respir Rev 2014; 23: 333-344
Year: 2014

Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015

Targeted screening programmes in COPD: how to identify individuals with alpha 1-antitrypsin deficiency
Source: Eur Respir Rev 2015; 24: 40-45
Year: 2015

Implementation of screening program for alpha-1 antitrypsin deficiency in Spain
Source: Annual Congress 2004 - Emphysema and oxygen therapy
Year: 2004

Unmet needs of asthma patients, and how these are reflected in attitudes to the disease and its treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 410s
Year: 2002

Physician perspectives: barriers to diagnosing and treating severe AATD
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017

Unmet medical need in respiratory disease: what needs modelling in animals
Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease
Year: 2007

Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011